Quantcast
Home / DC News / FDA stands ground on Pradaxa, but more suits filed

FDA stands ground on Pradaxa, but more suits filed

Litigation is moving forward against the makers of Pradaxa. More than 100 suits have been filed and the first cases have been scheduled, despite a recent safety review from the Food and Drug Administration concluding that the anticoagulant medicine does not pose a risk of serious internal bleeding.


Lawyers USA has ceased publication. If you have purchased a research pass or still have additional time on your current Digital Subscription, you may access locked stories by logging in:







Scroll To Top